It can, because it slows digestion
Puntos clave: Prdida de peso significativa: Promedio de 15% perdidos en comparacin con 2,6% con placebo Mejoras de salud: Impacto positivo sobre la presin arterial, el azcar en sangre, etc
These two quality failures are completely independent of each other
Gastrointestinal side effects, including nausea, constipation, diarrhea, and vomiting, were the most common complaint in both groups and were generally mild to moderate, occurring mostly during the dose escalation phase.[1] Injection site reactions were more common with tirzepatide (8.6% vs
If atorvastatin would bind and activate RyR2, the main isoform expressed in cardiac tissue, this could lead to dangerous arrhythmias similar to catecholaminergic polymorphic ventricular tachycardia (CPVT), frequently linked to gain-of-function mutations in RyR2 9,30